A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)

NCT03855358 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer (TNBC)

Interventions

DRUG: TQB2450 Injection and Anlotinib Hydrochioride Capsules

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.